Meta-unstable mRNAs in activated CD8+ T cells are defined by interlinked AU-rich elements and m6A mRNA methylation

CD8<sup>+</sup> T cells can rapidly produce effector molecules following activation. This activation triggers rapid changes in gene expression that rely on the control of mRNA levels via multiple mechanisms, including RNA modifications. N<sup>6</sup>-methyladenosine (m<sup>6</sup>A) is an abundant post-transcriptional modification that promotes the decay of messenger RNAs in the cytosol. However, how recognition of m<sup>6</sup>A sites is integrated with other regulatory mechanisms that alter the fate of immunoregulatory mRNAs in CD8<sup>+</sup> T cells remains unexplored. Here, we apply the m<sup>6</sup>A-iCLIP and GLORI methods to identify the importance of m<sup>6</sup>A sites flanked by AU-rich elements (AREs) within the 3'UTRs of CD8<sup>+</sup> T cell mRNAs. Presence of such ARE-flanking m<sup>6</sup>A motifs predicts meta-unstable mRNAs that rapidly decay upon CD8<sup>+</sup> T cell activation. We demonstrate interdependent effects of mutations in the identified AREs and RRACHs on TNF mRNA stability. The ARE-flanking m<sup>6</sup>A sites in these mRNAs show particularly high iCLIP crosslinking of YTHDF proteins, which are also identified by proteomic interactome analyses along with additional novel RNA-binding proteins. Our study reveals a crosstalk between m<sup>6</sup>A and ARE-dependent mechanisms in CD8<sup>+</sup> T cells, providing new approaches for modulating mRNA decay in T cell activation.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2026-01-22
DOI
https://doi.org/10.1038/s41467-025-67762-w
Citations
1
Primary Topic
RNA modifications and cancer
Type
article
Field-Weighted Citation Impact
22.24

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Meta-unstable mRNAs in activated CD8+ T cells are defined by interlinked AU-rich elements and m6A mRNA methylation

Paulo A. Gameiro, Klara Kuret, Nordin D. Zandhuis, Michiel Vermeulen et al.
1 citations
Nature Communications
RNA modifications and cancer
22.24
article

Meta-unstable mRNAs in activated CD8+ T cells are defined by interlinked AU-rich elements and m6A mRNA methylation

Paulo A. Gameiro, Klara Kuret, Nordin D. Zandhuis, Michiel Vermeulen, Jernej Ule, Iosifina P. Foskolou, Monika C. Wolkers, Žan Hozjan, Veronica Kot, Aniek A. M. Martens, Igor Ruiz de los Mozos, Randall S. Johnson, Yumna A. Butt
article en
1 citations

Abstract

CD8<sup>+</sup> T cells can rapidly produce effector molecules following activation. This activation triggers rapid changes in gene expression that rely on the control of mRNA levels via multiple mechanisms, including RNA modifications. N<sup>6</sup>-methyladenosine (m<sup>6</sup>A) is an abundant post-transcriptional modification that promotes the decay of messenger RNAs in the cytosol. However, how recognition of m<sup>6</sup>A sites is integrated with other regulatory mechanisms that alter the fate of immunoregulatory mRNAs in CD8<sup>+</sup> T cells remains unexplored. Here, we apply the m<sup>6</sup>A-iCLIP and GLORI methods to identify the importance of m<sup>6</sup>A sites flanked by AU-rich elements (AREs) within the 3'UTRs of CD8<sup>+</sup> T cell mRNAs. Presence of such ARE-flanking m<sup>6</sup>A motifs predicts meta-unstable mRNAs that rapidly decay upon CD8<sup>+</sup> T cell activation. We demonstrate interdependent effects of mutations in the identified AREs and RRACHs on TNF mRNA stability. The ARE-flanking m<sup>6</sup>A sites in these mRNAs show particularly high iCLIP crosslinking of YTHDF proteins, which are also identified by proteomic interactome analyses along with additional novel RNA-binding proteins. Our study reveals a crosstalk between m<sup>6</sup>A and ARE-dependent mechanisms in CD8<sup>+</sup> T cells, providing new approaches for modulating mRNA decay in T cell activation.

Nature CommunicationsVol. 17(1)
Radboud University Nijmegen (NL), University of Cambridge (GB), The Francis Crick Institute (GB), Radboud University Medical Center (NL), Karolinska Institutet (SE), The Netherlands Cancer Institute (NL), Sanquin (NL), Amsterdam Neuroscience (NL), Radboud Institute for Molecular Life Sciences (NL), Oncode Institute (NL), NIHR Queen Square Dementia Biomedical Research Unit (GB), National Hospital for Neurology and Neurosurgery (GB), National Institute of Chemistry (SI), University College London (GB), Universidade Nova de Lisboa (PT), University of Amsterdam (NL)
Wellcome Trust, Francis Crick Institute, National Institute for Health and Care Research, Cancerfonden, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Vetenskapsrådet, Barncancerfonden, Oncode Institute, Directorate for Biological Sciences, Medical Research Council
Openalex Percentile: Top 2%
RNA modifications and cancer
22.24
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.